Global Nucleic Acid Based Gene Therapy Market Research Report 2025(Status and Outlook)

March 2025 | 224 pages | ID: GEAE5489CB8CEN
Bosson Research

Abstracts

Report Overview

Gene therapy is used for correcting defective genes that are responsible for disease development. Moreover, nucleic acid-based therapeutics are used to treat genetic disorders and diseases for which there exists no permanent cure such as anaemia, sickle cell, cystic fibrosis, diabetes, and thalassemia.

This report provides a deep insight into the global Nucleic Acid Based Gene Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Nucleic Acid Based Gene Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Nucleic Acid Based Gene Therapy market in any manner.

Global Nucleic Acid Based Gene Therapy Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Wave Life Sciences

Imugene

Sarepta Therapeutics

Alnylam Pharmaceuticals

Ionis Pharmaceuticals

Moderna

BioNTech

Nutcracker Therapeutics

Deep Genomics

Sirnaomics

Laronde

Abogen Biosciences

Market Segmentation (by Type)

Anti-Sence and Anti-Gene

Short Inhibitory Sequences

Gene Transfer Therapy

Nucleoside Analogs

Ribozymes

Aptamers

Others

Market Segmentation (by Application)

Hospitals and Clinics

Academic and Research Institutes

Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Nucleic Acid Based Gene Therapy Market
• Overview of the regional outlook of the Nucleic Acid Based Gene Therapy Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nucleic Acid Based Gene Therapy Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Nucleic Acid Based Gene Therapy
1.2 Key Market Segments
1.2.1 Nucleic Acid Based Gene Therapy Segment by Type
1.2.2 Nucleic Acid Based Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Global Nucleic Acid Based Gene Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Nucleic Acid Based Gene Therapy Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Nucleic Acid Based Gene Therapy Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Global Nucleic Acid Based Gene Therapy Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Nucleic Acid Based Gene Therapy Product Life Cycle
3.3 Global Nucleic Acid Based Gene Therapy Sales by Manufacturers (2020-2025)
3.4 Global Nucleic Acid Based Gene Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Nucleic Acid Based Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Nucleic Acid Based Gene Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Nucleic Acid Based Gene Therapy Manufacturing Sites, Area Served, Product Type
3.8 Nucleic Acid Based Gene Therapy Market Competitive Situation and Trends
3.8.1 Nucleic Acid Based Gene Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Nucleic Acid Based Gene Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Nucleic Acid Based Gene Therapy Industry Chain Analysis
4.1 Nucleic Acid Based Gene Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Nucleic Acid Based Gene Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Nucleic Acid Based Gene Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Nucleic Acid Based Gene Therapy Market
5.7 ESG Ratings of Leading Companies
6 Global Nucleic Acid Based Gene Therapy Market by Region
6.1 Global Nucleic Acid Based Gene Therapy Market Size by Region
6.1.1 Global Nucleic Acid Based Gene Therapy Market Size by Region
6.1.2 Global Nucleic Acid Based Gene Therapy Market Size Market Share by Region
6.2 Global Nucleic Acid Based Gene Therapy Sales by Region
6.2.1 Global Nucleic Acid Based Gene Therapy Sales by Region
6.2.2 Global Nucleic Acid Based Gene Therapy Sales Market Share by Region
7 North America Market Overview
7.1 North America Nucleic Acid Based Gene Therapy Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Nucleic Acid Based Gene Therapy Market Size by Type
7.3 North America Nucleic Acid Based Gene Therapy Market Size by Application
8 Europe Market Overview
8.1 Europe Nucleic Acid Based Gene Therapy Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Nucleic Acid Based Gene Therapy Market Size by Type
8.3 Europe Nucleic Acid Based Gene Therapy Market Size by Application
9 Asia-Pacific Market Overview
9.1 Asia-Pacific Nucleic Acid Based Gene Therapy Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Nucleic Acid Based Gene Therapy Market Size by Type
9.3 Asia-Pacific Nucleic Acid Based Gene Therapy Market Size by Application
10 South America Market Overview
10.1 South America Nucleic Acid Based Gene Therapy Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Nucleic Acid Based Gene Therapy Market Size by Type
10.3 South America Nucleic Acid Based Gene Therapy Market Size by Application
11 Middle East and Africa Market Overview
11.1 Middle East and Africa Nucleic Acid Based Gene Therapy Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Nucleic Acid Based Gene Therapy Market Size by Type
11.3 Middle East and Africa Nucleic Acid Based Gene Therapy Market Size by Application
12 Nucleic Acid Based Gene Therapy Market Production by Region
12.1 Global Production of Nucleic Acid Based Gene Therapy by Region(2020-2025)
12.2 Global Nucleic Acid Based Gene Therapy Revenue Market Share by Region (2020-2025)
12.3 Global Nucleic Acid Based Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Nucleic Acid Based Gene Therapy Production
12.4.1 North America Nucleic Acid Based Gene Therapy Production Growth Rate (2020-2025)
12.4.2 North America Nucleic Acid Based Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Nucleic Acid Based Gene Therapy Production
12.5.1 Europe Nucleic Acid Based Gene Therapy Production Growth Rate (2020-2025)
12.5.2 Europe Nucleic Acid Based Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Nucleic Acid Based Gene Therapy Production (2020-2025)
12.6.1 Japan Nucleic Acid Based Gene Therapy Production Growth Rate (2020-2025)
12.6.2 Japan Nucleic Acid Based Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Nucleic Acid Based Gene Therapy Production (2020-2025)
12.7.1 China Nucleic Acid Based Gene Therapy Production Growth Rate (2020-2025)
12.7.2 China Nucleic Acid Based Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
13 Nucleic Acid Based Gene Therapy Market Segmentation by Type
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Nucleic Acid Based Gene Therapy Sales Market Share by Type (2020-2033)
13.3 Global Nucleic Acid Based Gene Therapy Market Size Market Share by Type (2020-2033)
13.4 Global Nucleic Acid Based Gene Therapy Price by Type (2020-2033)
14 Nucleic Acid Based Gene Therapy Market Segmentation by Application
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Nucleic Acid Based Gene Therapy Market Sales by Application (2020-2033)
14.3 Global Nucleic Acid Based Gene Therapy Market Size (M USD) by Application (2020-2033)
14.4 Global Nucleic Acid Based Gene Therapy Sales Growth Rate by Application (2020-2033)
15 Key Companies Profile
15.1 Wave Life Sciences
15.1.1 Wave Life Sciences Basic Information
15.1.2 Wave Life Sciences Nucleic Acid Based Gene Therapy Product Overview
15.1.3 Wave Life Sciences Nucleic Acid Based Gene Therapy Product Market Performance
15.1.4 Wave Life Sciences Business Overview
15.1.5 Wave Life Sciences SWOT Analysis
15.1.6 Wave Life Sciences Recent Developments
15.2 Imugene
15.2.1 Imugene Basic Information
15.2.2 Imugene Nucleic Acid Based Gene Therapy Product Overview
15.2.3 Imugene Nucleic Acid Based Gene Therapy Product Market Performance
15.2.4 Imugene Business Overview
15.2.5 Imugene SWOT Analysis
15.2.6 Imugene Recent Developments
15.3 Sarepta Therapeutics
15.3.1 Sarepta Therapeutics Basic Information
15.3.2 Sarepta Therapeutics Nucleic Acid Based Gene Therapy Product Overview
15.3.3 Sarepta Therapeutics Nucleic Acid Based Gene Therapy Product Market Performance
15.3.4 Sarepta Therapeutics Business Overview
15.3.5 Sarepta Therapeutics SWOT Analysis
15.3.6 Sarepta Therapeutics Recent Developments
15.4 Alnylam Pharmaceuticals
15.4.1 Alnylam Pharmaceuticals Basic Information
15.4.2 Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Product Overview
15.4.3 Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Product Market Performance
15.4.4 Alnylam Pharmaceuticals Business Overview
15.4.5 Alnylam Pharmaceuticals Recent Developments
15.5 Ionis Pharmaceuticals
15.5.1 Ionis Pharmaceuticals Basic Information
15.5.2 Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Product Overview
15.5.3 Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Product Market Performance
15.5.4 Ionis Pharmaceuticals Business Overview
15.5.5 Ionis Pharmaceuticals Recent Developments
15.6 Moderna
15.6.1 Moderna Basic Information
15.6.2 Moderna Nucleic Acid Based Gene Therapy Product Overview
15.6.3 Moderna Nucleic Acid Based Gene Therapy Product Market Performance
15.6.4 Moderna Business Overview
15.6.5 Moderna Recent Developments
15.7 BioNTech
15.7.1 BioNTech Basic Information
15.7.2 BioNTech Nucleic Acid Based Gene Therapy Product Overview
15.7.3 BioNTech Nucleic Acid Based Gene Therapy Product Market Performance
15.7.4 BioNTech Business Overview
15.7.5 BioNTech Recent Developments
15.8 Nutcracker Therapeutics
15.8.1 Nutcracker Therapeutics Basic Information
15.8.2 Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Product Overview
15.8.3 Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Product Market Performance
15.8.4 Nutcracker Therapeutics Business Overview
15.8.5 Nutcracker Therapeutics Recent Developments
15.9 Deep Genomics
15.9.1 Deep Genomics Basic Information
15.9.2 Deep Genomics Nucleic Acid Based Gene Therapy Product Overview
15.9.3 Deep Genomics Nucleic Acid Based Gene Therapy Product Market Performance
15.9.4 Deep Genomics Business Overview
15.9.5 Deep Genomics Recent Developments
15.10 Sirnaomics
15.10.1 Sirnaomics Basic Information
15.10.2 Sirnaomics Nucleic Acid Based Gene Therapy Product Overview
15.10.3 Sirnaomics Nucleic Acid Based Gene Therapy Product Market Performance
15.10.4 Sirnaomics Business Overview
15.10.5 Sirnaomics Recent Developments
15.11 Laronde
15.11.1 Laronde Basic Information
15.11.2 Laronde Nucleic Acid Based Gene Therapy Product Overview
15.11.3 Laronde Nucleic Acid Based Gene Therapy Product Market Performance
15.11.4 Laronde Business Overview
15.11.5 Laronde Recent Developments
15.12 Abogen Biosciences
15.12.1 Abogen Biosciences Basic Information
15.12.2 Abogen Biosciences Nucleic Acid Based Gene Therapy Product Overview
15.12.3 Abogen Biosciences Nucleic Acid Based Gene Therapy Product Market Performance
15.12.4 Abogen Biosciences Business Overview
15.12.5 Abogen Biosciences Recent Developments
16 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Nucleic Acid Based Gene Therapy Market Size by Type (M USD)
Table 4. Global Nucleic Acid Based Gene Therapy Market Size by Application (M USD)
Table 5. Nucleic Acid Based Gene Therapy Market Size Comparison by Region (M USD)
Table 6. Global Nucleic Acid Based Gene Therapy Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Nucleic Acid Based Gene Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Nucleic Acid Based Gene Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Nucleic Acid Based Gene Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Based Gene Therapy as of 2024)
Table 11. Global Market Nucleic Acid Based Gene Therapy Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Nucleic Acid Based Gene Therapy Manufacturing Sites and Area Served
Table 13. Manufacturers Nucleic Acid Based Gene Therapy Product Type
Table 14. Global Nucleic Acid Based Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Nucleic Acid Based Gene Therapy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Nucleic Acid Based Gene Therapy Market Size Comparison by Region (M USD)
Table 26. Global Nucleic Acid Based Gene Therapy Market Size by Region (2020-2033) & (M USD)
Table 27. Global Nucleic Acid Based Gene Therapy Market Size Market Share by Region (2020-2033)
Table 28. Global Nucleic Acid Based Gene Therapy Sales by Region (2020-2033) & (K MT)
Table 29. Global Nucleic Acid Based Gene Therapy Sales Market Share by Region (2020-2033)
Table 30. North America Nucleic Acid Based Gene Therapy Market Size by Country (2020-2033) & (M USD)
Table 31. North America Nucleic Acid Based Gene Therapy Sales by Country (2020-2033) & (K MT)
Table 32. North America Nucleic Acid Based Gene Therapy Sales by Type (K MT)
Table 33. North America Nucleic Acid Based Gene Therapy Market Size by Type (M USD)
Table 34. North America Nucleic Acid Based Gene Therapy Sales (K MT) by Type (2020-2033)
Table 35. North America Nucleic Acid Based Gene Therapy Market Size (M USD) by Type (2020-2033)
Table 36. North America Nucleic Acid Based Gene Therapy Sales by Application (K MT)
Table 37. North America Nucleic Acid Based Gene Therapy Market Size by Application (M USD)
Table 38. North America Nucleic Acid Based Gene Therapy Sales (K MT) by Application (2020-2033)
Table 39. North America Nucleic Acid Based Gene Therapy Market Size (M USD) by Application (2020-2033)
Table 40. Europe Nucleic Acid Based Gene Therapy Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Nucleic Acid Based Gene Therapy Sales by Country (2020-2033) & (K MT)
Table 42. Europe Nucleic Acid Based Gene Therapy Sales by Type (K MT)
Table 43. Europe Nucleic Acid Based Gene Therapy Market Size by Type (M USD)
Table 44. Europe Nucleic Acid Based Gene Therapy Sales (K MT) by Type (2020-2033)
Table 45. Europe Nucleic Acid Based Gene Therapy Market Size (M USD) by Type (2020-2033)
Table 46. Europe Nucleic Acid Based Gene Therapy Sales by Application (K MT)
Table 47. Europe Nucleic Acid Based Gene Therapy Market Size by Application (M USD)
Table 48. Europe Nucleic Acid Based Gene Therapy Sales (K MT) by Application (2020-2033)
Table 49. Europe Nucleic Acid Based Gene Therapy Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Nucleic Acid Based Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Nucleic Acid Based Gene Therapy Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Nucleic Acid Based Gene Therapy Sales by Type (K MT)
Table 53. Asia-Pacific Nucleic Acid Based Gene Therapy Market Size by Type (M USD)
Table 54. Asia-Pacific Nucleic Acid Based Gene Therapy Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Nucleic Acid Based Gene Therapy Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Nucleic Acid Based Gene Therapy Sales by Application (K MT)
Table 57. Asia-Pacific Nucleic Acid Based Gene Therapy Market Size by Application (M USD)
Table 58. Asia-Pacific Nucleic Acid Based Gene Therapy Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Nucleic Acid Based Gene Therapy Market Size (M USD) by Application (2020-2025)
Table 60. South America Nucleic Acid Based Gene Therapy Market Size by Country (2020-2033) & (M USD)
Table 61. South America Nucleic Acid Based Gene Therapy Sales by Country (2020-2033) & (K MT)
Table 62. South America Nucleic Acid Based Gene Therapy Sales by Type (K MT)
Table 63. South America Nucleic Acid Based Gene Therapy Market Size by Type (M USD)
Table 64. South America Nucleic Acid Based Gene Therapy Sales (K MT) by Type (2020-2033)
Table 65. South America Nucleic Acid Based Gene Therapy Market Size (M USD) by Type (2020-2033)
Table 66. South America Nucleic Acid Based Gene Therapy Sales by Application (K MT)
Table 67. South America Nucleic Acid Based Gene Therapy Market Size by Application (M USD)
Table 68. South America Nucleic Acid Based Gene Therapy Sales (K MT) by Application (2020-2033)
Table 69. South America Nucleic Acid Based Gene Therapy Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Nucleic Acid Based Gene Therapy Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Nucleic Acid Based Gene Therapy Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Nucleic Acid Based Gene Therapy Sales by Type (K MT)
Table 73. Middle East and Africa Nucleic Acid Based Gene Therapy Market Size by Type (M USD)
Table 74. Middle East and Africa Nucleic Acid Based Gene Therapy Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Nucleic Acid Based Gene Therapy Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Nucleic Acid Based Gene Therapy Sales by Application (K MT)
Table 77. Middle East and Africa Nucleic Acid Based Gene Therapy Market Size by Application (M USD)
Table 78. Middle East and Africa Nucleic Acid Based Gene Therapy Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Nucleic Acid Based Gene Therapy Market Size (M USD) by Application (2020-2033)
Table 80. Global Nucleic Acid Based Gene Therapy Production (K MT) by Region(2020-2025)
Table 81. Global Nucleic Acid Based Gene Therapy Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Nucleic Acid Based Gene Therapy Revenue Market Share by Region (2020-2025)
Table 83. Global Nucleic Acid Based Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Nucleic Acid Based Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Nucleic Acid Based Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Nucleic Acid Based Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Nucleic Acid Based Gene Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Nucleic Acid Based Gene Therapy Sales by Type (K MT)
Table 89. Global Nucleic Acid Based Gene Therapy Market Size by Type (M USD)
Table 90. Global Nucleic Acid Based Gene Therapy Sales (K MT) by Type (2020-2033)
Table 91. Global Nucleic Acid Based Gene Therapy Sales Market Share by Type (2020-2033)
Table 92. Global Nucleic Acid Based Gene Therapy Market Size (M USD) by Type (2020-2033)
Table 93. Global Nucleic Acid Based Gene Therapy Market Size Share by Type (2020-2033)
Table 94. Global Nucleic Acid Based Gene Therapy Sales (K MT) by Application
Table 95. Global Nucleic Acid Based Gene Therapy Market Size by Application(M USD)
Table 96. Global Nucleic Acid Based Gene Therapy Sales by Application (2020-2033) & (K MT)
Table 97. Global Nucleic Acid Based Gene Therapy Sales Market Share by Application (2020-2033)
Table 98. Global Nucleic Acid Based Gene Therapy Market Size by Application (2020-2033) & (M USD)
Table 99. Global Nucleic Acid Based Gene Therapy Market Share by Application (2020-2033)
Table 100. Global Nucleic Acid Based Gene Therapy Sales Growth Rate by Application (2020-2033)
Table 101. Wave Life Sciences Basic Information
Table 102. Wave Life Sciences Nucleic Acid Based Gene Therapy Product Overview
Table 103. Wave Life Sciences Nucleic Acid Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Wave Life Sciences Business Overview
Table 105. Wave Life Sciences SWOT Analysis
Table 106. Wave Life Sciences Recent Developments
Table 107. Imugene Basic Information
Table 108. Imugene Nucleic Acid Based Gene Therapy Product Overview
Table 109. Imugene Nucleic Acid Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Imugene Business Overview
Table 111. Imugene SWOT Analysis
Table 112. Imugene Recent Developments
Table 113. Sarepta Therapeutics Basic Information
Table 114. Sarepta Therapeutics Nucleic Acid Based Gene Therapy Product Overview
Table 115. Sarepta Therapeutics Nucleic Acid Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Sarepta Therapeutics Business Overview
Table 117. Sarepta Therapeutics SWOT Analysis
Table 118. Sarepta Therapeutics Recent Developments
Table 119. Alnylam Pharmaceuticals Basic Information
Table 120. Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Product Overview
Table 121. Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Alnylam Pharmaceuticals Business Overview
Table 123. Alnylam Pharmaceuticals Recent Developments
Table 124. Ionis Pharmaceuticals Basic Information
Table 125. Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Product Overview
Table 126. Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Ionis Pharmaceuticals Business Overview
Table 128. Ionis Pharmaceuticals Recent Developments
Table 129. Moderna Basic Information
Table 130. Moderna Nucleic Acid Based Gene Therapy Product Overview
Table 131. Moderna Nucleic Acid Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Moderna Business Overview
Table 133. Moderna Recent Developments
Table 134. BioNTech Basic Information
Table 135. BioNTech Nucleic Acid Based Gene Therapy Product Overview
Table 136. BioNTech Nucleic Acid Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. BioNTech Business Overview
Table 138. BioNTech Recent Developments
Table 139. Nutcracker Therapeutics Basic Information
Table 140. Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Product Overview
Table 141. Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Nutcracker Therapeutics Business Overview
Table 143. Nutcracker Therapeutics Recent Developments
Table 144. Deep Genomics Basic Information
Table 145. Deep Genomics Nucleic Acid Based Gene Therapy Product Overview
Table 146. Deep Genomics Nucleic Acid Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Deep Genomics Business Overview
Table 148. Deep Genomics Recent Developments
Table 149. Sirnaomics Basic Information
Table 150. Sirnaomics Nucleic Acid Based Gene Therapy Product Overview
Table 151. Sirnaomics Nucleic Acid Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. Sirnaomics Business Overview
Table 153. Sirnaomics Recent Developments
Table 154. Laronde Basic Information
Table 155. Laronde Nucleic Acid Based Gene Therapy Product Overview
Table 156. Laronde Nucleic Acid Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. Laronde Business Overview
Table 158. Laronde Recent Developments
Table 159. Abogen Biosciences Basic Information
Table 160. Abogen Biosciences Nucleic Acid Based Gene Therapy Product Overview
Table 161. Abogen Biosciences Nucleic Acid Based Gene Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. Abogen Biosciences Business Overview
Table 163. Abogen Biosciences Recent Developments
List of Figures
Figure 1. Product Picture of Nucleic Acid Based Gene Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nucleic Acid Based Gene Therapy Market Size (M USD), 2024-2033
Figure 5. Global Nucleic Acid Based Gene Therapy Market Size (M USD) (2020-2033)
Figure 6. Global Nucleic Acid Based Gene Therapy Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nucleic Acid Based Gene Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Nucleic Acid Based Gene Therapy Product Life Cycle
Figure 13. Nucleic Acid Based Gene Therapy Sales Share by Manufacturers in 2024
Figure 14. Global Nucleic Acid Based Gene Therapy Revenue Share by Manufacturers in 2024
Figure 15. Nucleic Acid Based Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Nucleic Acid Based Gene Therapy Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Nucleic Acid Based Gene Therapy Revenue in 2024
Figure 18. Industry Chain Map of Nucleic Acid Based Gene Therapy
Figure 19. Global Nucleic Acid Based Gene Therapy Market PEST Analysis
Figure 20. Global Nucleic Acid Based Gene Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Nucleic Acid Based Gene Therapy Market Size by Region
Figure 27. Global Nucleic Acid Based Gene Therapy Market Size Market Share by Region (2020-2033)
Figure 28. Global Nucleic Acid Based Gene Therapy Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Nucleic Acid Based Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Nucleic Acid Based Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Nucleic Acid Based Gene Therapy Market Size (M USD) by Country
Figure 33. USA Nucleic Acid Based Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Nucleic Acid Based Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Nucleic Acid Based Gene Therapy Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Nucleic Acid Based Gene Therapy Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Nucleic Acid Based Gene Therapy Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Nucleic Acid Based Gene Therapy Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Nucleic Acid Based Gene Therapy Market Size (M USD)by Type
Figure 40. North America Nucleic Acid Based Gene Therapy Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Nucleic Acid Based Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Nucleic Acid Based Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Nucleic Acid Based Gene Therapy Market Size (M USD) by Country
Figure 45. Germany Nucleic Acid Based Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Nucleic Acid Based Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Nucleic Acid Based Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Nucleic Acid Based Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Nucleic Acid Based Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Nucleic Acid Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Nucleic Acid Based Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Nucleic Acid Based Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Nucleic Acid Based Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Nucleic Acid Based Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Nucleic Acid Based Gene Therapy Market Size (M USD) by Type
Figure 56. Europe Nucleic Acid Based Gene Therapy Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Nucleic Acid Based Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Nucleic Acid Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Nucleic Acid Based Gene Therapy Market Size (M USD) by Country
Figure 61. China Nucleic Acid Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Nucleic Acid Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Nucleic Acid Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Nucleic Acid Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Nucleic Acid Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Nucleic Acid Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Nucleic Acid Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Nucleic Acid Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Nucleic Acid Based Gene Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Nucleic Acid Based Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Nucleic Acid Based Gene Therapy Market Size (M USD) by Type
Figure 72. Asia-Pacific Nucleic Acid Based Gene Therapy Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Nucleic Acid Based Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Nucleic Acid Based Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Nucleic Acid Based Gene Therapy Market Size (M USD) by Country
Figure 77. Brazil Nucleic Acid Based Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Nucleic Acid Based Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Nucleic Acid Based Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Nucleic Acid Based Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Nucleic Acid Based Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Nucleic Acid Based Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Nucleic Acid Based Gene Therapy Market Size (M USD) by Type
Figure 84. South America Nucleic Acid Based Gene Therapy Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Nucleic Acid Based Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Nucleic Acid Based Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Nucleic Acid Based Gene Therapy Market Size (M USD) by Country
Figure 89. Saudi Arabia Nucleic Acid Based Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Nucleic Acid Based Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Nucleic Acid Based Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Nucleic Acid Based Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Nucleic Acid Based Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Nucleic Acid Based Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Nucleic Acid Based Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Nucleic Acid Based Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Nucleic Acid Based Gene Therapy Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Nucleic Acid Based Gene Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Nucleic Acid Based Gene Therapy Market Size (M USD) by Type
Figure 100. Middle East and Africa Nucleic Acid Based Gene Therapy Market Size (M USD) by Application
Figure 101. Global Nucleic Acid Based Gene Therapy Production Market Share by Region (2020-2025)
Figure 102. North America Nucleic Acid Based Gene Therapy Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Nucleic Acid Based Gene Therapy Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Nucleic Acid Based Gene Therapy Production (K MT) Growth Rate (2020-2025)
Figure 105. China Nucleic Acid Based Gene Therapy Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Nucleic Acid Based Gene Therapy Market Size by Type (M USD)
Figure 108. Sales Market Share of Nucleic Acid Based Gene Therapy by Type (2020-2033)
Figure 109. Sales Market Share of Nucleic Acid Based Gene Therapy by Type in 2024
Figure 110. Market Size Share of Nucleic Acid Based Gene Therapy by Type (2020-2033)
Figure 111. Market Size Share of Nucleic Acid Based Gene Therapy by Type in 2024
Figure 112. Global Nucleic Acid Based Gene Therapy Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Nucleic Acid Based Gene Therapy Market Size by Application(M USD)
Figure 115. Global Nucleic Acid Based Gene Therapy Market Share by Application
Figure 116. Global Nucleic Acid Based Gene Therapy Sales Market Share by Application (2020-2033)
Figure 117. Global Nucleic Acid Based Gene Therapy Sales Market Share by Application in 2024
Figure 118. Global Nucleic Acid Based Gene Therapy Market Share by Application (2020-2033)
Figure 119. Global Nucleic Acid Based Gene Therapy Market Share by Application in 2024
Figure 120. Global Nucleic Acid Based Gene Therapy Sales Growth Rate by Application (2020-2033)